Multiple Myeloma Stem Cell Transplant Recovery

Before the transplant drug treatment is used to reduce the number of myeloma cells in the patient s body.

Multiple myeloma stem cell transplant recovery.

There can be a long period of dormancy that could. And the risk of side effects or complications is higher. Autologous stem cell transplant can provide significant remission that is both long and deep extending survival. Learn about the procedure costs risks and recovery of a bone marrow transplant.

The risk of infection is higher and lasts longer than in transplants using your own stem cells. Multiple myeloma isn t considered curable but symptoms wax and wane. In allogeneic transplantation stem cells are given by a donor most commonly a brother or sister. The 2 most common problems after this type of transplant are.

The standard of care for fit multiple myeloma patients is to receive high dose chemotherapy hdt with autologous stem cell rescue otherwise known as autologous stem cell transplant asct after completion of induction therapy. Autologous stem cell transplantation is more common for multiple myeloma but either type of transplant can be used. For an autologous stem cell transplant the. One viable treatment option for multiple myeloma patients is a stem cell transplant.

See drug therapy for multiple myeloma stem cell transplants sct can be autologous or allogeneic. Stem cell transplants have become important weapons in the fight against certain blood cancers such as multiple myeloma non hodgkin s lymphoma hodgkin lymphoma and leukemia a stem cell. In some cases a bone marrow or stem cell transplant is an option. Charlie rider had a stem cell transplant at dana farber as young boy.

Diagnosed with multiple myeloma in august 2010 she had a stem cell transplant in march 2011 and as of september 2013 was on post transplant maintenance bio therapy at dana farber brigham and women s cancer center. How you can help. Recovery after a donor transplant takes much longer. Stem cell transplant is commonly used to treat multiple myeloma.

We retrospectively analyzed multiple myeloma mm patients who underwent autologous stem cell transplantation asct without maintenance therapy to assess the impact of recovery of normal immunoglobulin ig on clinical outcomes.